<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="X-UA-Compatible" content="ie=edge" />
    <title>Document</title>
    <!-- Compiled and minified CSS -->
    <link
      rel="stylesheet"
      href="https://cdnjs.cloudflare.com/ajax/libs/materialize/1.0.0/css/materialize.min.css"
    />

    <!-- Compiled and minified JavaScript -->
    <script src="https://cdnjs.cloudflare.com/ajax/libs/materialize/1.0.0/js/materialize.min.js"></script>
    <link
      href="https://fonts.googleapis.com/icon?family=Material+Icons"
      rel="stylesheet"
    />

    <style>
      body{
        line-height: 1.9;
      }
      .tabs .tab a {
        color: #000;
      } /*Black color to the text*/

      .tabs .tab a:hover {
        background-color: rgb(124, 107, 255);
        color: #000;
      } /*Text color on hover*/

      .tabs .tab a.active {
        background-color: rgb(132, 118, 255);
        color: rgb(255, 255, 255);
      } /*Background and text color when a tab is active*/

      .tabs .indicator {
        background-color: #000;
      } /*Color of underline*/
      .tabs-content.carousel {
        height: 100%;
        overflow-x: hidden;
        overflow-y: scroll;
      }
      .tabs-content.carousel .carousel-item {
        width: 100%;
        height: 100%;
      }
      html,
      body {
        overflow: hidden;
        height: 100%;
      }
    </style>
  </head>
  <body>
      <img src="static//research-banner.jpg" style="width: 100%;max-height: 25%;">
    <ul id="tabs-swipe-Contacts" class="tabs">
      <li class="tab col s3">
        <a class="active" href="#Collaborations">Collaborations</a>
      </li>
      <li class="tab col s3"><a href="#RD">R&D Pipeline</a></li>
      <li class="tab col s3"><a href="#Publications">Publications</a></li>
    </ul>
    <div id="Collaborations" class="col s12">
      <div class="container">
        <h5 class="blue-text">National and International Collaborations</h5>
        <!-- <img src="static//research-banner.jpg"> -->
        <br />
        Over the years, R&D has forged numerous national and international
        collaborations in the area of vaccines, therapeutics and diagnostics,
        which has led to translation of research into number of commercialized
        products. Some of our collaborators are:<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Indian
        Veterinary Research Institute, Izatnagar, India<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Centre for
        Disease Control (CDC), USA<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Indian
        Institute of Sciences, Bangalore, India<br />
        <i class="material-icons tiny blue-text">chevron_right</i>National
        Institute of Health (NIH), USA<br />
        <i class="material-icons tiny blue-text">chevron_right</i>US Army
        Medical Research Institute of Infectious Diseases, USA<br />
        <i class="material-icons tiny blue-text">chevron_right</i>The Global
        Alliance for Livestock Veterinary Medicines (GALVmed), UK<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Centre for
        Disease Control, Taiwan<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Institute of
        Animal Health, UK<br />
        <i class="material-icons tiny blue-text">chevron_right</i>University of
        Melbourne, Australia<br />
      </div>
    </div>
    <div id="RD" class="col s12">
      <div class="container">
        <h5 class="blue-text">Current R&D Pipeline</h5>
        <br />
        R&D is engaged in development of a plethora of vaccines. Some of the
        products under advanced stages of development include: <br />
        <i class="material-icons tiny blue-text">chevron_right</i>Marker Vaccine
        for Infectious Bovine Rhinotracheitis<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Multicomponent
        Clostridial Vaccine<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Hepatitis A
        Vaccine<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Chikungunya
        Vaccine<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Japanese
        Encephalitis Vaccine<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Pneumococcal
        Conjugate Vaccine<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Typhoid
        Conjugate Vaccine<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Measles
        Rubella Vaccine<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Dengue
        Vaccine<br />
        <i class="material-icons tiny blue-text">chevron_right</i>Rabies
        therapeutic monoclonal antibodies<br />
      </div>
    </div>
    <div id="Publications" class="col s12">
      <div class="container">
        <h5 class="blue-text">Recent Publications</h5>
        <br />

        <h6>Veterinary</h6>
        <br />
        <ol>
          <li>
            Sridevi, N. V. et al. Development of anti-bovine IgA single chain
            variable fragment and its application in diagnosis of foot-and-mouth
            disease. Eur. J. Microbiol. Immunol. 4(1), 34–44 (2014).
          </li>
          <li>
            Yuvaraj, S. et al. Genetic and antigenic characterization of Indian
            foot-and-mouth disease virus serotype O isolates collected during
            the period 2001 to 2012. Infect. Genet. Evol. 13, 109-115 (2013).
          </li>
          <li>
            Yuvaraj, S. et al. A single amino acid deletion in capsid protein
            VP1 G-H loop region of a serotype O foot and mouth disease virus
            isolate from India. Curr. Trends Biotechnol. Pharm. 7(2), 597-602
            (2013).
          </li>
          <li>
            Yuvaraj, S. et al. Selection of foot and mouth disease virus
            candidate vaccine strain for serotype O. Curr. Trends Biotechnol.
            Pharm. 7(1), 550-555 (2013).
          </li>
          <li>
            Madhanmohan, M. et al. Development and evaluation of a real-time
            reverse transcription-loop-mediated isothermal amplification assay
            for rapid serotyping of foot-and-mouth disease virus. J. Virol.
            Methods 187(1), 195-202 (2013).
          </li>
          <li>
            Bhavani V. J. et al. Determination of threshold stimulation index
            for IGRAs using ESAT-6 and CFP-10 antigens for bovine TB diagnostics
            in India. Int. J. Pharm Bio Sci. 3(4), 740-749 (2012).
          </li>
          <li>
            Mohana, S. B. et al. Development of foot-and-mouth disease virus
            (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation
            of its potency. Antiviral Res. 96(3), 288-295 (2012).
          </li>
          <li>
            Madhanmohan, M. et al. Clinical protection, sub-clinical infection
            and persistence following vaccination with extinction payloads of O1
            Manisa Foot-and-Mouth disease monovalent vaccine and challenge in
            goats and comparison with sheep. Res. Vet. Sci. 93(2), 1050-1059
            (2012).
          </li>
          <li>
            Sathish, K. et al. Oral immunization of birds against recombinant
            Eimera antigens: An approach for vaccinating poultry birds against
            coccidiosis. Curr. Trends Biotechnol. Pharm. 6(3), 312-321 (2012).
          </li>
          <li>
            Naidu, H. et al. Typing of canine parvovirus isolates using
            mini-sequencing based single nucleotide polymorphism analysis. J.
            Virol. Methods 181 (2), 197-201 (2012).
          </li>
          <li>
            Sathish, K. et al. Plant expressed coccidial antigens as potential
            vaccine candidates in protecting chicken against coccidiosis.
            Vaccine 30(30), 4460-4464 (2012).
          </li>
          <li>
            Trangadia, B. J. et al. Serological investigation of bovine
            brucellosis, Johne’s disease and infectious bovine rhinotracheitis
            in two states of India. J. Adv. Vet. Res. 2(1), 38-41 (2012).
          </li>
          <li>
            Trangadia, B. J. et al. Evaluation of fluorescence polarization
            assay for the diagnosis of brucellosis in cattle and buffaloes in
            India. Ind. J. Anm. Sci. 82(6), 561-564 (2012).
          </li>
          <li>
            Veerasami, M. et al. Multi-antigen print immunoassay for
            seroepidemiological surveillance of bovine tuberculosis on Indian
            cattle farms. Vet. Ital. 48(3), 253-267 (2012).
          </li>
          <li>
            Madhanmohan, M. et al. Transmission of foot-and-mouth disease virus
            from experimentally infected Indian buffalo (Bubalus bubalis) to
            in-contact naïve and vaccinated Indian buffalo and cattle. Vaccine
            31, 5125-5130 (2014).
          </li>
          <li>
            Abhinay, G. et al. A novel site-II directed glycoprotein estimation
            ELISA to aid rabies vaccine manufacture for veterinary and human
            use. Vaccine 32, 209-213 (2014).
          </li>
          <li>
            Gangadhararao, A. et al. Ante-mortem and post-mortem examinations of
            the cattle calf naturally infected with Mycobacterium avium subsp.
            paratuberculosis. Eur. J. Microbiol. Immunol. 3(4), 241–251 (2013).
          </li>
          <li>
            Parthasarathy, S. et al. Use of ESAT-6-CFP-10 fusion protein in the
            bovine interferon-gamma ELISPOT assay for diagnosis of Mycobacterium
            bovis infection in cattle. J. Microbiol. Methods 90(3), 298-304
            (2012).
          </li>
        </ol>
        <br />
        <h6>Human</h6>
        <br />
        <ol>
          <li>
            Shahana, P. V. et al. Efficient production of Tymovirus like
            particles displaying immunodominant epitopes of Japanese
            Encephalitis Virus envelope protein. Protein Expr. Purif. 113, 35-43
            (2015).
          </li>
          <li>
            Verma, R. R. et al. Seroprevalence of Antibodies to HPV L1 in a
            limited population study determined by the GST-Capture ELISA. Curr.
            Trends Biotechnol. Pharm. 9(2), 97- 106 (2015).
          </li>
          <li>
            Neelakantam, B. et al. Identification and Characterization of Novel
            Binding Epitope of Tetanus toxoid by Phage Display Peptide Library.
            Curr. Trends Biotechnol. Pharm. 9 (1), 49-58 (2015).
          </li>
          <li>
            Shukra, A. et al. Production of Recombinant Antibodies using
            Bacteriophages. Eur. J. Microbiol. Immunol. 4 (2), 91–98 (2014).
          </li>
          <li>
            Neelakantam, B. et al. Recombinant human antibody fragment against
            tetanus toxoid produced by phage display. Eur. J. Microbiol.
            Immunol. 4 (1), 45–55 (2014).
          </li>
          <li>
            Ramya, R. et al. Assessment of packed bed bioreactor systems in the
            production of viral vaccines. AMB Express 4, 25 (2014).
          </li>
          <li>
            Vidyasagar, P. et al. Generation and characterization of
            neutralizing monoclonal antibodies against baculo-expressed HPV 16
            VLPs. Eur. J. Microbiol. Immunol. 4(1), 56-64 (2014).
          </li>
          <li>
            Shahana, P.V. et al. Japanese Encephalitis: An overview of vaccine
            development. Curr. Trends Biotechnol. Pharm. 8 (3), 303-308 (2014).
          </li>
          <li>
            Rajendar, B. et al. A simple and rapid method to monitor the
            disassembly and reassembly of virus-like particles. Anal. Biochem.
            440(1), 15–17 (2013).
          </li>
          <li>
            Shahana, P.V. et al. Enhancement of Japanese Encephalitis Virus DNA
            vaccine efficacy by using Mycobacterium avium paratuberculosis heat
            shock protein 65. Curr. Trends Biotechnol. Pharm. 7(4), 904-913
            (2013).
          </li>
          <li>
            Verma, R. R. et al. E6 protein of Human Papillomavirus 16 (HPV16)
            expressed in Escherichia coli sans a stretch of hydrophobic amino
            acids, enables purification of GST-ΔE6 in the soluble form and
            retains the binding ability to p53. Protein Expr. Purif. 92(1),
            41-47 (2013).
          </li>
          <li>
            Ramya, R. et al. Immuno-affinity purification of insect cell
            expressed rabies virus glycoprotein using a conformational specific
            monoclonal antibody. J. Adv. Vet. Res. 2(4), 232-238 (2012).
          </li>
          <li>
            Nimmagadda, S. V. et al. Development of recombinant single-chain
            variable fragment against hepatitis A virus and its use in
            quantification of hepatitis A antigen. Biologicals 40(4), 299-308
            (2012).
          </li>
          <li>
            Ponnanna, N. M. et al. Construction of a vector for the constitutive
            expression of Human Papillomavirus type 16 genes in Salmonella
            enterica serovar Typhi strain Ty21a. Curr. Trends Biotechnol. Pharm.
            6(3), 373-380 (2012).
          </li>
          <li>
            Ponnanna, N. M. et al. T cell response to oncoprotein E7 of Human
            Papillomavirus genotype 16 (HPV 16) delivered by Salmonella typhi
            strain Ty21a (S. typhi Ty21a) in mice. Curr. Trends Biotechnol.
            Pharm. 6(4), 398-406 (2012).
          </li>
        </ol>
        <br><br>
        <br />
      </div>
    </div>
    <br>
    <script>
      var el = document.querySelector(".tabs");
      var instance = M.Tabs.init(el, {
        duration: 300,
        swipeable: true
      });
    </script>
  </body>
</html>
